Funder
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference28 articles.
1. Samulski R, Muzyczka N. AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol. 2014;1:427–51.
2. Bi L. Summary basis for regulatory action -Luxturna. Food and Drug Administration (FDA), May, 2019.
3. Byrnes A. Summary basis for regulatory action - Zolgensma. Food and Drug Administration (FDA), May, 2019.
4. Xiong W, Wu D, Xue Y, Wang S, Chung M, Ji X, et al. AAV Cis-regulatory sequences are correlated with ocular toxicity. Proc Natl Acad Sci USA. 2019;116:5785–94.
5. Evans A, Thadani N, Suh J. Biocomputing nanoplatforms as therapeutics and diagnostics.J. Control. Release Soc.2016;240:387–93.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献